LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods ...
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. Simulations Plus announced that the U.S. Food and Drug Administration has added licenses of its GastroPlus for ...
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NAS: SLP) , a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that ...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it ...
RESEARCH TRIANGLE, N.C.--(BUSINESS WIRE)-- Simulations Plus, Inc. (SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and ...
, a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that the U.S. Food and Drug Administration has added licenses of GastroPlus™ for ...
LANCASTER, Calif., Aug 24, 2010 (BUSINESS WIRE) -- Simulations Plus, Inc., a leading provider of simulation and modeling software for pharmaceutical discovery and development, has announced the launch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results